Aspirin Discontinuation Guidelines Before Cervical Epidural Procedures

Rationale for Aspirin Discontinuation

Aspirin irreversibly inhibits platelet function for the entire lifespan of platelets (7-10 days), making timing of discontinuation critical for invasive procedures 1
For procedures with high bleeding risk, such as neuraxial interventions, a complete correction of platelet function is necessary in all patients, requiring a 5-7 day washout period 1
Epidural procedures are classified as moderate to high-risk interventions that warrant appropriate antiplatelet medication management, according to the Association of Anaesthetists of Great Britain & Ireland 2

The Association of Anaesthetists of Great Britain & Ireland recommends stopping aspirin at least 3 days before moderate to high-risk procedures like epidurals 2
For procedures with high bleeding risk (including neuraxial procedures), the French Working Group on Perioperative Haemostasis recommends a 5-day aspirin washout period 1
Central neuraxial anesthesia may be performed in patients on aspirin monotherapy if the benefit-risk ratio is favorable, but a longer discontinuation period is preferred for optimal safety 3

For patients with high cardiovascular risk (recent myocardial infarction or cardiac stent placement), the American Family Physician suggests that the continuation of aspirin may be considered after careful risk-benefit assessment 4
Patients with drug-eluting stents at high risk of thrombosis may need to postpone elective procedures until 6 months to 1 year after stent placement, as recommended by Praxis Medical Insights 5

Aspirin can typically be resumed 12-24 hours after the procedure when adequate hemostasis has been achieved, according to Praxis Medical Insights 5
For patients with aspirin-exacerbated respiratory disease who have undergone desensitization, gaps in aspirin doses >48 hours may lead to loss of tolerance, as reported in the Journal of Allergy and Clinical Immunology 6

The French Working Group on Perioperative Haemostasis recommends a 5-day washout period for aspirin before neuraxial procedures, which are classified as high bleeding risk interventions requiring complete correction of platelet function 7

Aspirin should ideally be continued perioperatively when possible in patients with high cardiovascular risk, as the thrombotic risk may outweigh bleeding risk 7, 8
If epidural anesthesia is essential in these patients, the procedure should be postponed until DAPT duration is complete, or performed only after multidisciplinary discussion weighing catastrophic bleeding vs thrombotic risks 7, 8

Restart aspirin the same day if adequate hemostasis is achieved, to minimize thrombotic risk in patients requiring antiplatelet therapy 7, 8

Do not assume 3 days is sufficient for high-risk neuraxial procedures—the 5-day minimum provides better safety margins 7
Do not overlook that epidural catheter manipulation and removal carry the same bleeding risks as insertion—apply the same aspirin discontinuation criteria 7, 8
Do not perform epidurals in patients on dual antiplatelet therapy (aspirin plus P2Y12 inhibitors) unless both agents have been discontinued for appropriate intervals (aspirin 5 days, clopidogrel 7 days, ticagrelor 5 days) 7, 8